EFFECT OF LOW-DOSE BOLUS, LOW-DOSE CONTINUOUS INFUSION, AND HIGH-DOSE CONTINUOUS INFUSION INTERLEUKIN-2 ON INVIVO AND INVITRO GENERATION OF LYMPHOKINE ACTIVATED KILLER CELL-ACTIVITY

被引：0
|
作者：
BOLTON, JS
CHOI, YS
COOPER, ES
FLAUM, MA
LEAVITT, D
机构：
[1] ALTON OCHSNER MED FDN & OCHSNER CLIN,DEPT SURG,NEW ORLEANS,LA 70121
[2] HOFFMANN LA ROCHE INC,NUTLEY,NJ 07110
来源：
CLINICAL RESEARCH | 1989年 / 37卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A23 / A23
页数：1
相关论文
共 50 条
  • [21] LOW-DOSE CYCLOPHOSPHAMIDE AND LOW-DOSE INTERLEUKIN-2 FOR MALIGNANT-MELANOMA
    MITCHELL, MS
    KEMPF, RA
    HAREL, W
    SHAU, H
    BOSWELL, WD
    LIND, S
    DEAN, G
    MOORE, J
    BRADLEY, EC
    BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1989, 65 (01) : 128 - 144
  • [22] COMPARISON OF HIGH-DOSE AND LOW-DOSE INSULIN BY CONTINUOUS INTRAVENOUS-INFUSION IN THE TREATMENT OF DIABETIC-KETOACIDOSIS IN CHILDREN
    BURGHEN, GA
    ETTELDORF, JN
    FISHER, JN
    KITABCHI, AE
    DIABETES CARE, 1980, 3 (01) : 15 - 80
  • [23] High-dose continuous infusion plus pulse interleukin-2 and famotidine in melanoma
    Quan, W
    Ramirez, M
    Taylor, WC
    Vinogradov, M
    Khan, N
    Jackson, S
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (06) : 770 - 775
  • [24] High-dose continuous infusion plus pulse interleukin-2 and famotidine in melanoma
    Quan, WDY
    Taylor, WC
    Ramirez, M
    Vinogradov, M
    Khan, N
    Jackson, S
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S5 - S6
  • [25] PROLONGED CONTINUOUS-INFUSION OF LOW-DOSE RIL-2 - REPLY
    VLASVELD, LT
    RANKIN, EM
    MELIEF, CJM
    BRITISH JOURNAL OF CANCER, 1994, 69 (05) : 977 - 977
  • [26] SELECTIVE MODULATION OF HUMAN NATURAL-KILLER-CELLS INVIVO AFTER PROLONGED INFUSION OF LOW-DOSE RECOMBINANT INTERLEUKIN-2
    CALIGIURI, MA
    MURRAY, C
    ROBERTSON, MJ
    WANG, E
    COCHRAN, K
    CAMERON, C
    SCHOW, P
    ROSS, ME
    KLUMPP, TR
    SOIFFER, RJ
    SMITH, KA
    RITZ, J
    JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01): : 123 - 132
  • [27] A PHASE-II STUDY OF HIGH-DOSE CONTINUOUS INFUSION INTERLEUKIN-2 WITH LYMPHOKINE-ACTIVATED KILLER-CELLS IN PATIENTS WITH METASTATIC MELANOMA
    DUTCHER, JP
    GAYNOR, ER
    BOLDT, DH
    DOROSHOW, JH
    BAR, MH
    SZNOL, M
    MIER, J
    SPARANO, J
    FISHER, RI
    WEISS, G
    MARGOLIN, K
    ARONSON, FR
    HAWKINS, M
    ATKINS, M
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (04) : 641 - 648
  • [28] IMMUNOMODULATORY EFFECTS OF SYSTEMIC LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS IN HUMANS
    EBERLEIN, TJ
    RODRICK, ML
    MASSARO, AF
    JUNG, SE
    MANNICK, JA
    SCHOOF, DD
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1989, 30 (03) : 145 - 150
  • [29] Prevention of injection pain by prior continuous infusion of low-dose propofol
    Terada, H
    Ohta, S
    Nishikawa, T
    NEW BALANCED ANESTHESIA, 1998, 1164 : 199 - 200
  • [30] INCIDENCE OF ADVERSE CARDIOPULMONARY EFFECTS WITH LOW-DOSE CONTINUOUS TERBUTALINE INFUSION
    PERRY, KG
    MORRISON, JC
    RUST, OA
    SULLIVAN, CA
    MARTIN, RW
    NAEF, RW
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (04) : 1273 - 1277
12345